NCT03780725View on ClinicalTrials.gov

This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

February 19, 2020

Study Completion Date

December 8, 2020

Conditions
Carcinoma, Non-Small-Cell LungHead and Neck Neoplasms
Interventions
DRUG

BI 754111

Solution for infusion

DRUG

[89Zr]Zr-BI 754111

Solution for infusion

DRUG

BI 754091

Solution for infusion

Trial Locations (1)

1081HV

Amsterdam UMC Locatie VUMC, Amsterdam

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03780725 - This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 | Biotech Hunter | Biotech Hunter